- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Celldex Therapeutics Inc
+ Add to WatchlistCLDX:US
15.2000 USD 0.2000 1.30%As of 20:10:00 ET on 06/19/2013.
Snapshot for Celldex Therapeutics Inc (CLDX)
| Open: | 15.4800 | Day's Range: | 15.1000 - 15.6000 | Volume: | 1,140,524 |
|---|---|---|---|---|---|
| Previous Close: | 15.4000 | 52wk Range: | 4.3609 - 16.4800 | 1-Yr Rtn: | +237.78% |
Key Statistics for CLDX
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (USD) (ttm) | -0.9800 |
| Est. EPS (USD) (12/2013) | -0.9300 |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 1,229.23 |
| Shares Outstanding (M) | 80.87 |
| 30 Day Average Volume | 1,492,435 |
| Price/Book (mrq) | 6.3056 |
| Price/Sale (ttm) | 85.6460 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/09/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for CLDX
Company Profile & Key Executives for CLDX
Celldex Therapeutics Inc., a biopharmaceutical company, uses applications of immunology to prevent and treat diseases. The Company's products treat autoimmune diseases, cardiovascular diseases, cancer, and inflammation, as well as infectious diseases and organ transplant rejection.
| Anthony Salvatore MarucciPresident/CEO | Avery W Catlin "Chip"Senior VP/CFO/Secretary |
| Thomas DavisSenior VP/Chief Medical Ofcr | Tibor KelerSenior VP/Chief Scientific Ofcr |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
CLDX News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page